Suppression of the gut microbiome ameliorates age‐related arterial dysfunction and oxidative stress in mice

Abstract

Key pointsr Age-related arterial dysfunction, characterized by oxidative stress-and inflammation-mediated endothelial dysfunction and arterial stiffening, is the primary risk factor for cardiovascular diseases.Vienna E. Brunt received her PhD in Human Physiology from the University of Oregon in 2016. She is currently a postdoctoral fellow in Dr D. R. Seals' Integrative Physiology of Aging Laboratory at the University of Colorado Boulder. The studies described in the present study represent work carried out as part of an NIH T32 fellowship through the Division of Cardiology at the University of Colorado Denver. Her long-term research goals are to investigate the efficacy of novel interventions for preserving vascular function with ageing, thereby preventing and/or delaying the progression of cardiovascular diseases. Rachel A. Gioscia-Ryan completed her PhD in the Integrative Physiology of Aging Laboratory at the University of Colorado Boulder in 2016 and is currently in medical school at the University of Michigan. She is pursuing a career as a clinician-scientist conducting integrative physiological studies with the aim of improving human health and patient care. * These authors contributed equally to this work.Abstract Oxidative stress-mediated arterial dysfunction (e.g. endothelial dysfunction and large elastic artery stiffening) is the primary mechanism driving age-related cardiovascular diseases. Accumulating evidence suggests the gut microbiome modulates host physiology because dysregulation ('gut dysbiosis') has systemic consequences, including promotion of oxidative stress. The present study aimed to determine whether the gut microbiome modulates arterial function with ageing. We measured arterial function in young and older mice after 3-4 weeks of treatment with broad-spectrum, poorly-absorbed antibiotics to suppress the gut microbiome. To identify potential mechanistic links between the gut microbiome and age-related arterial dysfunction, we sequenced microbiota from young and older mice and measured plasma levels of the adverse gut-derived metabolite trimethylamine N-oxide (TMAO). In old mice, antibiotics reversed endothelial dysfunction [area-under-the-curve carotid artery dilatation to acetylcholine in young: 345 ± 16 AU vs. old control (OC): 220 ± 34 AU, P < 0.01; vs. old antibiotic-treated (OA): 334 ± 15 AU; P < 0.01 vs. OC] and arterial stiffening (aortic pulse wave velocity in young: 3.62 ± 0.15 m s −1 vs. OC: 4.43 ± 0.38 m s −1 ; vs. OA: 3.52 ± 0.35 m s −1 ; P = 0.03). These improvements were accompanied by lower oxidative stress and greater antioxidant enzyme expression. Ageing altered the abundance of gut microbial taxa associated with gut dysbiosis. Lastly, plasma TMAO was higher with ageing (young: 2.6 ± 0.4 μmol L −1 vs. OC: 7.2 ± 2.0 μmol L −1 ; P < 0.0001) and suppressed by antibiotic treatment (OA: 1.2 ± 0.2 μmol L −1 ; P < 0.0001 vs. OC). The results of the present study provide the first evidence for the gut microbiome being an important mediator of age-related arterial dysfunction and ...

Preliminary Biochemical Description of Brain Oxidative Stress Status in Irritable Bowel Syndrome Contention-Stress Rat Model

“…However, the oxidative stress role in IBS was not fully understood due to the many implications that the other components of IBS could have on the yet nonspecific oxidative changes. For example, it was also demonstrated that gut microbiome suppression could lead to important changes in oxidative status [16,17].…”

Is the fountain of youth in the gut microbiome?

“…Moreover, both aortic stiffening and its associated elastin fibre degradation was completely reversed following antibiotics to a level that resulted them being indistinguishable from those seen in young mice (Brunt et al . ).…”

“…In this issue of The Journal of Physiology Brunt et al . () tackle this question directly with a fascinating series of experiments in the mouse. Remarkably, they show that suppression of the gut microbiome using broad‐spectrum antibiotics restored arterial function in old mice (26–27 months old) to levels observed in young animals (5–6 months old) and this was coupled with a normalization of both oxidative stress and inflammation.…”

Gut microbiota: a promising target against cardiometabolic diseases

“…The effect on potential clinical outcomes should still be evaluated. Nevertheless, a rodent study demonstrated endothelial dysfunction reversal after a poorly absorbed antibiotic cocktail supplementation in old mice [165]. Another study showed that oral vancomycin administration in metabolic syndrome subjects influenced bile acid metabolism and decreased insulin sensitivity [166].…”